127 related articles for article (PubMed ID: 30219827)
41. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release.
Wang Q; Li Y; Liu SA; Xie W; Cheng J
World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605
[TBL] [Abstract][Full Text] [Related]
42. Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication.
Lin HM; Wu PS; Hu HS; Chang WC; Wu RH; Tian JN; Chern JH; Yueh A
J Virol Methods; 2018 Sep; 259():10-17. PubMed ID: 29782889
[TBL] [Abstract][Full Text] [Related]
43. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
[TBL] [Abstract][Full Text] [Related]
44. Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime.
Arita M; Wakita T; Shimizu H
J Gen Virol; 2009 Aug; 90(Pt 8):1869-1879. PubMed ID: 19439558
[TBL] [Abstract][Full Text] [Related]
45. Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives.
Salim MT; Aoyama H; Sugita K; Watashi K; Wakita T; Hamasaki T; Okamoto M; Urata Y; Hashimoto Y; Baba M
Biochem Biophys Res Commun; 2011 Dec; 415(4):714-9. PubMed ID: 22085716
[TBL] [Abstract][Full Text] [Related]
46. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
[TBL] [Abstract][Full Text] [Related]
47. Recrutement des kinases PI4KIII aux organelles de réplication virale au cours de l'infection par le poliovirus et d'autres virus à ARN de polarité positive.
Blondel B; Mirabelli C; Pelletier I; Téoulé F; Muslin C; Joffret ML; Colbère-Garapin F; Delpeyroux F
Virologie (Montrouge); 2014 Oct; 18(5):251-263. PubMed ID: 33065919
[TBL] [Abstract][Full Text] [Related]
48. New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication.
Himmelsbach K; Sauter D; Baumert TF; Ludwig L; Blum HE; Hildt E
Gut; 2009 Dec; 58(12):1644-53. PubMed ID: 19710032
[TBL] [Abstract][Full Text] [Related]
49. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.
Berger KL; Cooper JD; Heaton NS; Yoon R; Oakland TE; Jordan TX; Mateu G; Grakoui A; Randall G
Proc Natl Acad Sci U S A; 2009 May; 106(18):7577-82. PubMed ID: 19376974
[TBL] [Abstract][Full Text] [Related]
50. Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors.
Lamarche MJ; Borawski J; Bose A; Capacci-Daniel C; Colvin R; Dennehy M; Ding J; Dobler M; Drumm J; Gaither LA; Gao J; Jiang X; Lin K; McKeever U; Puyang X; Raman P; Thohan S; Tommasi R; Wagner K; Xiong X; Zabawa T; Zhu S; Wiedmann B
Antimicrob Agents Chemother; 2012 Oct; 56(10):5149-56. PubMed ID: 22825118
[TBL] [Abstract][Full Text] [Related]
51. Foot-and-mouth disease virus replicates independently of phosphatidylinositol 4-phosphate and type III phosphatidylinositol 4-kinases.
Berryman S; Moffat K; Harak C; Lohmann V; Jackson T
J Gen Virol; 2016 Aug; 97(8):1841-1852. PubMed ID: 27093462
[TBL] [Abstract][Full Text] [Related]
52. Colony-forming assays reveal enhanced suppression of hepatitis C virus replication using combinations of direct-acting antivirals.
Graham EJ; Hunt R; Shaw SM; Pickford C; Hammond J; Westby M; Targett-Adams P
J Virol Methods; 2011 Jun; 174(1-2):153-7. PubMed ID: 21473883
[TBL] [Abstract][Full Text] [Related]
53. Stearoyl coenzyme A desaturase 1 is associated with hepatitis C virus replication complex and regulates viral replication.
Nguyen LN; Lim YS; Pham LV; Shin HY; Kim YS; Hwang SB
J Virol; 2014 Nov; 88(21):12311-25. PubMed ID: 25122791
[TBL] [Abstract][Full Text] [Related]
54. Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin.
Pisonero-Vaquero S; García-Mediavilla MV; Jorquera F; Majano PL; Benet M; Jover R; González-Gallego J; Sánchez-Campos S
Lab Invest; 2014 Mar; 94(3):262-74. PubMed ID: 24492281
[TBL] [Abstract][Full Text] [Related]
55. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.
Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
J Virol; 2013 Apr; 87(8):4252-60. PubMed ID: 23365445
[TBL] [Abstract][Full Text] [Related]
56. Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.
Liu S; Nelson CA; Xiao L; Lu L; Seth PP; Davis DR; Hagedorn CH
Antiviral Res; 2011 Jan; 89(1):54-63. PubMed ID: 21075143
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironment.
Li H; Yang X; Yang G; Hong Z; Zhou L; Yin P; Xiao Y; Chen L; Chung RT; Zhang L
J Virol; 2014 Jun; 88(11):5956-66. PubMed ID: 24623438
[TBL] [Abstract][Full Text] [Related]
58. ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication.
Zhang L; Hong Z; Lin W; Shao RX; Goto K; Hsu VW; Chung RT
PLoS One; 2012; 7(2):e32135. PubMed ID: 22359663
[TBL] [Abstract][Full Text] [Related]
59. Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection.
Gastaminza P; Pitram SM; Dreux M; Krasnova LB; Whitten-Bauer C; Dong J; Chung J; Fokin VV; Sharpless KB; Chisari FV
J Virol; 2011 Jun; 85(11):5513-23. PubMed ID: 21430055
[TBL] [Abstract][Full Text] [Related]
60. Ferrocene-based inhibitors of hepatitis C virus replication that target NS5A with low picomolar in vitro antiviral activity.
Gadhachanda VR; Eastman KJ; Wang Q; Phadke AS; Patel D; Yang W; Marlor CW; Deshpande M; Huang M; Wiles JA
Bioorg Med Chem Lett; 2018 Nov; 28(21):3463-3471. PubMed ID: 30290989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
